Table 1.

Symptoms and implantable loop recorder recordings

Day	State	Symptoms	Trough rhythm and rate	Therapy
0		ILR implanted	Sinus rhythm	None
1	Sleep	Sleep syncope	35.6 s pause	None
9	Sleep	Asleep	27 s pause	Atomoxetine 40 mg daily
10	Awake	Presyncope	40 bpm for 16 s	Atomoxetine 40 mg bid
32	Awake	Presyncope	40 bpm for 30 s	Atomoxetine 40 mg bid
33	Awake	Presyncope ×3	50 bpm 50 s	Atomoxetine 40 mg bid
34	Awake	Presyncope	42 bpm 42 s	Atomoxetine 40 mg bid
70	Awake	Presyncope	75 bpm 30 s	Atomoxetine 40 mg bid
72	Awake	Presyncope	60 bpm 30 s	Atomoxetine 40 mg bid
73	Awake	Presyncope	54 bpm 20 s	Atomoxetine 40 mg bid
112	Awake	Presyncope	33 bpm	Atomoxetine 40 mg bid
114	Asleep	Asleep	5 s sinus pause	Atomoxetine 40 mg bid
114	Asleep	Asleep	6 s sinus pause	Atomoxetine 40 mg bid
129	Awake	Presyncope ×3	Mobitz 1 2nd degree AV block	Atomoxetine 40 mg bid
131	Asleep	Presyncope ×2	10 s 2nd degree AV block	Atomoxetine 40 mg bid
133	Awake, supine	Presyncope	2nd degree AV block	Atomoxetine 40 mg bid

AV = atrioventricular; bid = twice a day; bpm = beats per minute; ILR = implantable loop recorder.

The suppression of vagal asystole was associated with atomoxetine 40 bid (P = .032, Fisher exact). There was no sleep syncope and a reduction in asystole while taking atomoxetine 40 mg bid.